Overview


Amylase is an enzyme that aids in breaking down carbohydrates, particularly starch. It is primarily produced by the salivary glands in the mouth and the pancreas. When you eat carbohydrates, amylase helps break down the starch into smaller sugar molecules, such as maltose, which can be easily absorbed by the body. However, in certain medical conditions, the levels of amylase in the blood or other body fluids can become elevated or decreased, indicating potential issues with the pancreas, salivary glands, or other related organs. Amylase testing refers to the measurement of amylase levels in the blood or other body fluids to diagnose various medical conditions.

Amylase testing is frequently utilized to diagnose and keep track of pancreas-related conditions, particularly acute or chronic pancreatitis. Pancreatitis is a condition in which the pancreas becomes inflamed, leading to symptoms such as abdominal pain, nausea, vomiting, and other symptoms. Elevated amylase levels in the blood or urine are often seen in cases of acute pancreatitis, helping to confirm the diagnosis. There are two primary types of amylases that can be measured in the body: serum amylase and urinary amylase. Serum amylase is measured using a blood sample, while urinary amylase is measured in a urine sample. The results of these tests, along with other clinical information, can aid doctors in making a proper diagnosis and determining the appropriate treatment plan.

FutureWise Market Research has published a report that provides an insightful analysis of Amylase Testing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Amylase Testing Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Amano Enzyme
  • Novozymes
  • DSM
  • BASF
  • Advanced Enzyme Tech.
  • Suzhou Sino Enzymes
  • Shenzhen Leveking Bio-Engineering
  • Chemzyme Biotechnology
  • Enmex
  • Biolaxi

(Note: The list of the major players will be updated with the latest market scenario and trends)

The amylase testing market is a significant segment within the broader field of medical diagnostics, driven by the growing prevalence of pancreatic and salivary gland-related disorders. Amylase testing plays a crucial role in diagnosing and monitoring conditions like acute and chronic pancreatitis, as well as diseases affecting the salivary glands. As these conditions continue to be a significant healthcare concern worldwide, the demand for amylase testing is expected to witness steady growth. One of the key drivers of the amylase testing market is the rising incidence of pancreatitis. Lifestyle factors such as consuming excessive amounts of alcohol, unhealthy diets, and smoking contribute to an increased risk of pancreatitis. Additionally, the aging population is prone to pancreatic disorders, further fueling the demand for amylase testing as elderly individuals are more susceptible to these conditions. Moreover, advancements in medical technology and diagnostic tools have led to the development of more accurate and efficient amylase testing methods, enhancing their adoption by healthcare providers. Furthermore, the growing understanding among the public about the significance of detecting diseases early is aiding the market's growth. Regular health check-ups are becoming more common, prompting individuals to undergo routine tests, including amylase testing, to identify any potential health problems at an early stage. Early detection leads to timely intervention and better management of conditions, leading to improved patient outcomes.

Although there are factors driving the amylase testing market, there are also restraints that could impede its growth. One of the primary challenges is the high cost associated with advanced amylase testing technologies. These tests often require sophisticated equipment and skilled personnel, making them expensive for certain healthcare facilities and patients. Additionally, reimbursement policies and coverage for amylase testing may vary, limiting access to these tests for some individuals, especially in low-income regions.

By Type

  • Blood Sample Testing
  • Urine Sample Testing

By Application

  • Hospital
  • Clinic
  • Diagnostic Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America dominates the amylase testing market, holding a substantial share due to its advanced healthcare infrastructure, high prevalence of pancreatic disorders, and rising awareness of early disease detection. The region benefits from well-established healthcare facilities, cutting-edge diagnostic technologies, and a higher level of healthcare spending, facilitating widespread availability and adoption of amylase testing. Lifestyle factors contribute to a higher incidence of pancreatitis, prompting increased demand for amylase testing to diagnose and monitor these conditions.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Amylase Testing Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Amylase Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amylase Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Amylase Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Amylase Testing Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Sample Testing
        2. Urine Sample Testing

  • 8.   Global Amylase Testing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Clinic
        3. Diagnostic Laboratories

  • 9.   North America Amylase Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Amylase Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Amylase Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Amylase Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Amano Enzyme
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Novozymes
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. DSM
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. BASF
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Advanced Enzyme Tech.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Suzhou Sino Enzymes
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Shenzhen Leveking Bio-Engineering
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Chemzyme Biotechnology
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Enmex
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Biolaxi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients